FDA Inspection 1148504 — Aesculap Inc

Aesculap Inc — FEI 2916714

The FDA completed an inspection of Aesculap Inc on Aug 11, 2021 in Center Valley, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 11, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Center Valley, PA (United States)

Citations

IDCFRDescription
342621 CFR 820.50(a)(1)Documented evaluation
63021 CFR 803.17Lack of Written MDR Procedures
73121 CFR 803.50(a)(1)Report of Death or Serious Injury

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.